← Leaderboards
Fredrick Heath Damron
West Virginia University
$7,032,693
Attributed
$7,032,693
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,017,693 · 3
FDA$15,000 · 1
By mechanism
R01$7,012,693 · 2
R13$20,000 · 2
Top collaborators
No co-investigators on record.
Most similar at West Virginia University
Same institution · by research overlap
- Mariette Barbier$8,169,304
Others in their field
Other Emerging Leaders on “Life”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Martha Hering · Westat, Inc.$57,098,843
Research focus
LifeIncidencePublic HealthRespiratory Tract InfectionsPathogenMissionPertussisPertussis VaccineUnited States National Institutes Of HealthVaccinesChildBordetella PertussisImmunizeAdjuvantHuman PathogenHemagglutininImmunityInfantAntigensDoseIntramuscularDiphtheriaAcellular VaccinesAdult
Grant awards (12)
Development of mRNA-platform vaccines$807,427
R01 · FY2025 · AI · contact PI
Development of mRNA-platform vaccines$812,208
R01 · FY2024 · AI · contact PI
Development of mRNA-platform vaccines$841,516
R01 · FY2023 · AI · contact PI
Development of mucosal vaccines to protect against pertussis$585,615
R01 · FY2023 · AI · contact PI
Development of mRNA-platform vaccines$833,885
R01 · FY2022 · AI · contact PI
Development of mucosal vaccines to protect against pertussis$529,130
R01 · FY2022 · AI · contact PI
13th International Bordetella Symposium$15,000
R13 · FY2022 · FD · contact PI
International Bordetella Symposia$5,000
R13 · FY2022 · AI · contact PI
Development of mRNA-platform vaccines$826,282
R01 · FY2021 · AI · contact PI
Development of mucosal vaccines to protect against pertussis$592,210
R01 · FY2021 · AI · contact PI
Development of mucosal vaccines to protect against pertussis$592,210
R01 · FY2020 · AI · contact PI
Development of mucosal vaccines to protect against pertussis$592,210
R01 · FY2019 · AI · contact PI